Detalhe da pesquisa
1.
Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia.
J Med Econ;
27(1): 134-144, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38163926
2.
The economic burden of viral severe acute respiratory infections in the Kingdom of Saudi Arabia: A nationwide cost-of-illness study.
IJID Reg;
10: 80-86, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38173861
3.
Cost-Utility of Immunosuppressive Therapy Post-Renal Transplantation in Saudi Arabia: The Saudi Ministry of Health Perspective.
Value Health Reg Issues;
33: 56-64, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36244306
4.
Overview of Procurement and Reimbursement of Pharmaceuticals in Saudi Arabia, United Arab Emirates, Qatar, and Egypt: Challenges and Opportunities.
Glob J Qual Saf Healthc;
6(4): 127-136, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38404458
5.
Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia.
Ann Saudi Med;
37(6): 433-443, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29229891